June 2016 – Butterfly is pleased to support Dr Glenn Flux and team in their new research : “Investigation of the role of protein bound iodine in radio iodine treatment of thyroid cancer: a sub study of the SELIMETRY trial”, which will examine if there is a correlation between the protein bound iodine measurements and the absorbed doses delivered, and if there is a correlation between the protein bound iodine measurements and treatment outcome. Research will be carried out over 4 years and 60 patients will be recruited into the trial.

James Salter Research Grant 2015 winner

Butterfly is delighted to announce that the James Salter Research Grant Award 2015 has gone to Dr Kate Newbold from the Royal Marsden. Dr Newbold says :

We are delighted to hear that the Butterfly Trust has chosen to support our research study investigating novel biomarkers in thyroid cancer. The aim of this project is to gain a better understanding of the natural history of thyroid cancer with a hope that this will enable us to detect at an earlier stage and with more accuracy when the cancer recurs or progresses. Now that we are in an era of targeted therapies we hope to be able to identify the mutations occurring in tumours with the goal to tailor treatments to an individual patient’s cancer. We hope that this will lead to improved control of disease whilst minimising toxicities of therapies by avoiding drugs or interventions that are unlikely to work for particular tumours.

The Butterfly Trust provides such a valuable service to individual patients but also to the wider thyroid cancer community by raising awareness of this rare, but increasingly frequent, cancer. We are therefore thrilled and proud to be able to start this exciting collaboration with Butterfly.

BTCT is a National Institute for Health Research (NIHR) Non-Commercial Partner

Appropriate research studies funded through BTCT’S s Research Fund are now automatically eligible for NIHR Clinical Research Network (CRN) support and therefore entitled to:

  • Use of the NIHR Coordinated System for gaining NHS Permissions (NIHR CSP) which is accessed via the Integrated Research Application System (IRAS)
  • Access NHS support via the NIHR Clinical Research Network.

Please note that to be eligible for NIHR CRN support any research study we fund must also meet the standard study eligibility criteria, namely that it:

  • Requires NHS Research Ethics Committee approval and NHS permission
  • Is a discrete structured research project with an appropriate study protocol
  • Is of clear value to the NHS
  • Involves NHS patients, staff, premises, facilities or resources

We are available on this number Monday to Friday from 10 am to 4 pm. Outside these times, please leave a message on our answer phone and we will get back to you as soon as we can.